Clinical Trial Update: Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating HFR-SUPRA for treatment of multiple myeloma-related acute kidney injury (not yet recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Multiple Myeloma

Drugs mentioned

• HFR-SUPRA (HFR-SUPRA)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Multiple Myeloma, Acute Kidney Injury | Phase 4 | Status: NOT_YET_RECRUITING